Review revealed prevalence declining in more recent years, but remains high
FRIDAY, Oct. 21, 2022 (HealthDay News) — More than one-quarter of patients with rheumatoid arthritis (RA) have osteoporosis, according to a study published online Sept. 23 in Scientific Reports.
Samaneh Moshayedi, from Arak University of Medical Sciences in Iran, and colleagues conducted a systematic literature review to assess the global prevalence of osteoporosis among RA patients.
Based on 57 studies (including 227,812 cases of RA with 64,290 cases of osteoporosis), the researchers found that the summary point prevalence of osteoporosis among RA was 27.6 percent. Prevalence may be declining, with the highest prevalence seen in studies conducted during 2011 to 2015 (36.2 percent) compared with 2016 to 2021 (27.1 percent). Geographically, the highest prevalence of osteoporosis was seen in Africa (46.1 percent), followed by Asia (30.6 percent), Europe (25.6 percent), and the Americas (19.5 percent).
“Despite significant advances in prevention, treatment, and diagnostic methods in RA patients, it still seems that the prevalence of osteoporosis in these patients is high and requires better and timelier interventions,†the authors write.
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints 
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder 
Exposure to Air Pollutants Linked to Increased RA Disease Activity 
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA 
